Interestingly, combining EGFR-TKIs with TP4 enhanced cytotoxicity to EGFR-activated NSCLC cells (Figure 1E,F), suggesting that blockage of EGFR signaling contributes to TP4-mediated cytotoxicity. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.